Clinical Trials on Influenza Type A in Hong Kong

Total 1394 results

Chinese University of Hong Kong
University of Malaya

Terminated

Risk of Hepatitis Flare in Patients With Previous Hepatitis B Virus Exposure Amongst Patients

Immunosuppression | Occult Hepatitis B | Biological Substance; Adverse Effect

Hong Kong
F-star Therapeutics, Inc.
PRA Health Sciences

Terminated

Evaluating the Safety and Efficacy of Inarigivir in Non-cirrhotic Treatment Naive Subjects Infected With Hepatitis B Virus

Hepatitis B | Hepatitis B, Chronic | HBV

Hong Kong
Humanity and Health Research Centre

Recruiting

Change of Renal Function and Bone Mineral Density in CHB Patients Switch From TDF to TAF vs. Maintaining TDF (SWITAF)

Chronic Hepatitis B

Hong Kong
Chinese University of Hong Kong

Completed

Seroepidemiology of Viral Hepatitis in Hong Kong

Viral Hepatitis

China
Novartis Pharmaceuticals

Completed

Early add-on Vildagliptin in Patients With Type 2 Diabetes Inadequately Controlled by Metformin

Type-2 Diabetes Mellitus

Hong Kong
Chinese University of Hong Kong

Withdrawn

Paricalcitol for the Treatment of Immunoglobulin A Nephropathy

IgA Nephropathy

Hong Kong
Biolingus
Chinese University of Hong Kong

Recruiting

Safety, Tolerability and Preliminary Efficacy of Sublingual Liraglutide in Patients With Type 2 Diabetes Mellitus

Diabete Type 2

Hong Kong
The University of Hong Kong

Unknown

Promoting Insulin Initiation Among Suboptimal Diabetic Control Patients

Type 2 Diabetes

Hong Kong
The University of Hong Kong
Hospital Authority, Hong Kong

Completed

Quality of Life and Health Utility of Patients With CHB Infections

Chronic Hepatitis B Infection

Hong Kong
GlaxoSmithKline

Completed

Immunogenicity of GSK Biologicals' Pandemic Influenza Vaccine (GSK1562902A) at Different Boosting Vaccination Schedules

Influenza

Taiwan, Hong Kong, Thailand, Singapore
The University of Hong Kong

Completed

Metabolic Responses of Dapagliflozin vs Sitagliptin in T2DM Patients Inadequately Controlled With Insulin Therapy

Type 2 Diabetes | Ketonemia

Hong Kong
Chinese University of Hong Kong

Completed

JanUmet Before Insulin Lantus In Eastern Population Evaluation Program (JUBILEE) In Type 2 Diabetic Patients (JUBILEE)

Type 2 Diabetes Mellitus

Hong Kong
Chinese University of Hong Kong
Asia Diabetes Foundation

Completed

Community Health Worker Reduces Care Utilization (JADE-MOS)

Type 2 Diabetes Mellitus

Hong Kong
Chinese University of Hong Kong

Completed

Self-care Management Programme for Type 2 Adult DM Patients With Poor Glycemic Control (T2DM)

Type 2 Diabetes

Hong Kong
The University of Hong Kong

Completed

Evaluation of Paternal, Maternal and Obstetric Factors Leading to the Hepatitis B Immunization Failure in Hong Kong

Hepatitis B Infection

China
The University of Hong Kong

Not yet recruiting

Digital Lifestyle Intervention For Diabetes/Pre-Diabetes

Obesity | PreDiabetes | Type 2 Diabetes

Hong Kong
The University of Hong Kong

Completed

Renoprotective Effects of Telbivudine in Chronic Hepatitis B

Chronic Kidney Diseases | Hepatitis B, Chronic

Hong Kong
Chinese University of Hong Kong

Completed

ACT-DE for Diabetes Distress in Adults With Type 2 Diabetes: A Pilot RCT (ACT-DE)

Type 2 Diabetes | Acceptance and Commitment Therapy | Diabetes Distress

Hong Kong
Hospital Authority, Hong Kong

Completed

A Study to Investigate Whether the Immediate Use or Deferred Use of an Anti-viral Drug Lamivudine Will Help to Better Safe-guard the Delivery of Chemotherapy in Patients With Cancer Who Are Also Hepatitis B Carriers

Neoplasms | Hepatitis B

China
The University of Hong Kong
Queen Mary Hospital, Hong Kong

Completed

BLI, NBI or White Light Colonoscopy for Proximal Colonic Adenoma (BNW)

Colon Adenoma

Hong Kong
Chinese University of Hong Kong

Completed

Treatment for Bile Duct Cancer in the Liver

Cholangio Carcinoma

Hong Kong
Novartis Pharmaceuticals

Completed

Effects of Telbivudine and Tenofovir Disoproxil Fumarate Treatment on the Hepatitis B Virus DNA Kinetics in CHB

Hepatitis B Virus

China
Chinese University of Hong Kong

Unknown

Does AI-assisted Colonoscopy Improve Adenoma Detection in Screening Colonoscopy?

Screening Colonoscopy

Hong Kong
Chinese University of Hong Kong

Completed

The Effect of Taking Break During Colonoscopy Session on Adenoma Detection, a Prospective, Randomized Control Study

Colonic Adenoma

Hong Kong
The University of Hong Kong

Completed

Xeloxiri as First-line Treatment in Patients With Advanced Unresectable Pancreatic Adenocarcinoma

Pancreatic Adenocarcinoma

Hong Kong
Hospital Authority, Hong Kong
Vigconic (International) Ltd.

Completed

A Phase II, Double-blinded, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Vitalliver in Patients With Decompensated Cirrhosis

Liver Cirrhosis | Hepatitis B | Hepatitis C

China
The University of Hong Kong
Janssen, LP

Unknown

Efficacy and Safety of Ibrutinib in Patients With CLL and Other Indolent B-cell Lymphomas Who Are Chronic Hepatitis B Virus Carriers or Occult Hepatitis B Virus Carriers

Follicular Lymphoma | Chronic Hepatitis B | Chronic Lymphocytic Leukemia | Mantle-Cell Lymphoma | Lymphoma, Small Lymphocytic | Indolent B-cell Lymphomas | Waldenstrom's Macroglobulinaemia

Hong Kong
Chinese University of Hong Kong

Completed

Randomised Placebo-controlled Study of FMT to Impact Body Weight and Glycemic Control in Obese Subjects With T2DM

Type 2 Diabetes Mellitus | Type2 Diabetes | Obese

Hong Kong
Pamela Youde Nethersole Eastern Hospital

Terminated

Renal Denervation Therapy for Resistant Hypertension in Type 2 Diabetes Mellitus (HTN2DM)

Diabetes Mellitus | Hypertension, Resistant | Renal Denervation Therapy

Hong Kong
NovoCure GmbH
Zai Lab (Shanghai) Co., Ltd.

Unknown

Effect of Tumor Treating Fields (TTFields, 150 kHz) Concomitant With Chemotherapy as First Line Treatment of Unresectable Gastroesophageal Junction or Gastric Adenocarcinoma

Gastric Cancer | GastroEsophageal Cancer

Hong Kong
The University of Hong Kong

Active, not recruiting

Full-scale Intervention Study: Genetic Risk Communication and Wearables

Physical Activity | Type 2 Diabetes | Genetic Predisposition to Disease | Exercise | Fitness Trackers

Hong Kong
The University of Hong Kong

Completed

Intra-dermal With Topical Imiquimod Pretreatment Versus Intra-muscular Hepatitis B Vaccination in IBD Patients

Hepatitis B | Inflammatory Bowel Diseases

China
The University of Hong Kong
Novartis Pharmaceuticals

Completed

Effects of Telbivudine and Tenofovir Disproxil Fumarate on the Kinetics of Hepatitis B Virus DNA in Chronic Hepatitis B (CHB)

Chronic Hepatitis B

China
The University of Hong Kong

Recruiting

Intervention Study: Genetic Risk Communication and Wearables

Type 2 Diabetes | Genetic Predisposition to Disease | Exercise | Sedentary Behavior | Fitness Trackers

Hong Kong
Chinese University of Hong Kong

Completed

Treatment of Early Immunoglobulin A Nephropathy by Angiotensin Converting Enzyme Inhibitor - A Randomized Controlled Trial

Normal Blood Pressure | Biopsy-confirmed IgA Nephropathy | Proteinuria Less Than 0.5 g Per Day | Serum Creatinine Below 120 Umol/l

Hong Kong
The University of Hong Kong

Completed

Clofarabine, Cytarabine and Mitoxantrone (CLAM) for Relapsed or Refractory AML

Acute Myeloid Leukemia

Hong Kong
The University of Hong Kong

Recruiting

The Acute Promyelocytic Leukaemia Asian Consortium (APL-AC) Project

Acute Promyelocytic Leukemia

Hong Kong
Bio-Cancer Treatment International Limited

Unknown

Efficacy and Safety Study of Recombinant Human Arginase 1 in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Acute Myeloid Leukemia

Hong Kong
Chinese University of Hong Kong
Shenzhen Hospital of Southern Medical University; The Fifth Affiliated Hospital... and other collaborators

Recruiting

Hybrid APC for Gastric Low Grade Intraepithelial Neoplasia (HybridAPC)

Gastric Low Grade Intraepithelial Neoplasia

Hong Kong
The University of Hong Kong

Unknown

SIMPLE Chemotherapy for NK Lymphoma/Leukaemia

Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type | Non-Hodgkin's Lymphoma, Relapsed | Non-Hodgkin T-cell Lymphoma

Hong Kong
The University of Hong Kong

Recruiting

Frontline Oral Arsenic Trioxide for APL

Acute Promyelocytic Leukemia

Hong Kong
GlaxoSmithKline

Completed

Lamivudine Plus Interferon Versus Lamivudine For The Treatment Of HBeAg Positive Chronic Hepatitis B Virus (HBV)

Chronic Hepatitis B

Hong Kong
Chinese University of Hong Kong

Terminated

A Study on the Angioarchitecture of Hepatocellular Carcinoma

Carcinoma, Hepatocellular

Hong Kong
The University of Hong Kong
Janssen, LP

Recruiting

The Use of Decitabine as Induction Therapy for Acute Myeloid Leukemia With Complex and/or Monosomal Karyotype

Acute Myeloid Leukemia | Complex Karyotype

Hong Kong
Chinese University of Hong Kong

Recruiting

Endoscopic Closure of Gastric ESD Defect

Gastric Dysplasia | Gastric Cancer in Situ

Hong Kong
Chinese University of Hong Kong

Completed

Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes

Diabetes Mellitus, Type 2

Hong Kong
Chinese University of Hong Kong
Hospital Authority, Hong Kong

Terminated

Telephone Intervention in Patients With Acute Coronary Syndrome (ACS) and Diabetes

Type 2 Diabetes Mellitus | Acute Coronary Syndrome

Hong Kong
The University of Hong Kong

Recruiting

Real Time Effective Withdrawal Time and Adenoma Detection Rate

Artificial Intelligence | Colon Adenoma | Colon Polyp

Hong Kong
Chinese University of Hong Kong
Health and Medicine Research Fund

Recruiting

Laparoscopic Versus Open Major Hepatectomy for HCC Hepatectomy for Hepatocellular Carcinoma (AP-LAPO)

Hepatocellular Carcinoma

Hong Kong
Chinese University of Hong Kong
The Hong Kong Society of Gastroenterology

Completed

Cytokine Change in Hepatocellular Carcinoma Treated by Thermal Ablation

Hepatocellular Carcinoma

Hong Kong

Clinical Trials on Influenza Type A in Hong Kong

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Arab Emirates

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations